Reunion Neuroscience Correlations
| REUNDelisted Stock | USD 1.12 0.01 0.90% |
A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Reunion Neuroscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Reunion Neuroscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Reunion Neuroscience Correlation With Market
Good diversification
The correlation between Reunion Neuroscience and DJI is -0.1 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Reunion Neuroscience and DJI in the same portfolio, assuming nothing else is changed.
Reunion |
Moving together with Reunion Stock
| 0.69 | CNOBP | ConnectOne Bancorp | PairCorr |
| 0.8 | GLPPRB | Global Partners LP | PairCorr |
| 0.85 | SAPMF | Saipem SpA | PairCorr |
| 0.85 | GIFI | Gulf Island Fabrication | PairCorr |
| 0.79 | NBIX | Neurocrine Biosciences | PairCorr |
| 0.87 | SUM | Summit Materials | PairCorr |
| 0.7 | RCMT | RCM Technologies | PairCorr |
| 0.78 | RWAYL | MSCI ACWI exAUCONSUMER | PairCorr |
| 0.84 | HUT | Hut 8 Corp | PairCorr |
| 0.79 | ZWS | Zurn Elkay Water | PairCorr |
| 0.8 | YPF | YPF Sociedad Anonima | PairCorr |
| 0.8 | FBMS | First Bancshares, Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.66 | DMRC | Digimarc | PairCorr |
| 0.84 | HAFC | Hanmi Financial Fiscal Year End 28th of January 2025 | PairCorr |
| 0.85 | TGTX | TG Therapeutics | PairCorr |
| 0.74 | GLABF | Gemina Laboratories Earnings Call This Week | PairCorr |
| 0.75 | PETS | PetMed Express | PairCorr |
| 0.69 | GM | General Motors | PairCorr |
| 0.83 | BSIG | Brightsphere Investment | PairCorr |
Moving against Reunion Stock
| 0.89 | CMXHF | CSL Limited | PairCorr |
| 0.88 | CSLLY | CSL | PairCorr |
| 0.87 | REGN | Regeneron Pharmaceuticals | PairCorr |
| 0.72 | NVO | Novo Nordisk AS | PairCorr |
| 0.71 | NONOF | Novo Nordisk AS | PairCorr |
| 0.71 | QSAM | Qsam Biosciences | PairCorr |
| 0.68 | MEDS | Trxade Group Symbol Change | PairCorr |
| 0.55 | 251566AA3 | DT 3625 21 | PairCorr |
| 0.47 | BYDDY | BYD Co | PairCorr |
| 0.43 | GDSTW | Goldenstone Acquisition | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Reunion Stock performing well and Reunion Neuroscience Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Reunion Neuroscience's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| BRAXF | 12.56 | 2.08 | 0.07 | (1.23) | 12.22 | 50.00 | 133.33 | |||
| ONTTF | 4.05 | (0.15) | 0.00 | (0.09) | 0.00 | 12.03 | 25.17 | |||
| AGNPF | 6.87 | (0.02) | 0.00 | 0.00 | 7.79 | 16.58 | 55.53 | |||
| AWKNF | 6.14 | 0.53 | 0.04 | (0.40) | 7.30 | 18.00 | 43.08 | |||
| ACUT | 6.28 | (0.31) | 0.00 | (0.05) | 0.00 | 19.35 | 56.07 | |||
| NUVL | 1.64 | (0.32) | 0.00 | (0.20) | 0.00 | 2.66 | 13.19 | |||
| OKYO | 2.61 | 0.15 | 0.03 | (0.22) | 3.14 | 4.81 | 29.99 | |||
| OCTHF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| NTII | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| PHGUF | 0.74 | 0.17 | 0.00 | (0.71) | 0.00 | 0.00 | 21.69 |
View Reunion Neuroscience Related Equities
| Risk & Return | Correlation |
Reunion Neuroscience Corporate Management
| MD MBA | VP Director | Profile | |
| Nathan BSc | Chief Officer | Profile | |
| Stephan Cote | Head Quality | Profile | |
| Hannan Fleiman | CoFounder Director | Profile | |
| Mujeeb Jafferi | COFounder COO | Profile | |
| Edward CPA | Chief Officer | Profile | |
| Vicki Reed | Chief Officer | Profile |
Still Interested in Reunion Neuroscience?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.